- Home
- RVTY vs SNN Comparison
RVTY vs SNN Comparison
Compare RVTY & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVTY
- SNN
- Stock Information
- Founded
- RVTY 1937
- SNN 1856
- Country
- RVTY United States
- SNN United Kingdom
- Employees
- RVTY N/A
- SNN N/A
- Industry
- RVTY Biotechnology: Laboratory Analytical Instruments
- SNN Industrial Specialties
- Sector
- RVTY Industrials
- SNN Health Care
- Exchange
- RVTY Nasdaq
- SNN Nasdaq
- Market Cap
- RVTY 11.4B
- SNN 13.2B
- IPO Year
- RVTY N/A
- SNN 1999
- Fundamental
- Price
- RVTY $82.88
- SNN $37.76
- Analyst Decision
- RVTY Buy
- SNN Hold
- Analyst Count
- RVTY 13
- SNN 3
- Target Price
- RVTY $120.08
- SNN $31.50
- AVG Volume (30 Days)
- RVTY 1.1M
- SNN 639.9K
- Earning Date
- RVTY 11-03-2025
- SNN 10-30-2025
- Dividend Yield
- RVTY 0.34%
- SNN 1.94%
- EPS Growth
- RVTY 72.56
- SNN 59.91
- EPS
- RVTY 2.37
- SNN 0.56
- Revenue
- RVTY $2,798,467,000.00
- SNN $5,944,000,000.00
- Revenue This Year
- RVTY $5.55
- SNN $7.75
- Revenue Next Year
- RVTY $4.40
- SNN $5.37
- P/E Ratio
- RVTY $35.00
- SNN $67.67
- Revenue Growth
- RVTY 3.33
- SNN 5.35
- 52 Week Low
- RVTY $81.36
- SNN $23.69
- 52 Week High
- RVTY $129.50
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- RVTY 39.80
- SNN 59.87
- Support Level
- RVTY $82.47
- SNN $37.92
- Resistance Level
- RVTY $85.86
- SNN $38.59
- Average True Range (ATR)
- RVTY 2.69
- SNN 0.38
- MACD
- RVTY -0.38
- SNN -0.15
- Stochastic Oscillator
- RVTY 11.84
- SNN 54.42
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.